Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Lordick, F; Ehlken, B; Ihbe-Heffinger, A; Berger, K; Krobot, KJ; Pellissier, J; Davies, G; Deuson, R 
Titel:
Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany. 
Abstract:
BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) remains a major adverse effect of cancer therapy. We aimed to determine outcomes associated with use of aprepitant in outpatients undergoing highly emetogenic chemotherapy in Germany from a patient's and payer's perspective. METHODS: A decision-analytic model compared an aprepitant regimen (aprepitant/ondansetron/dexamethasone) to a control regimen (ondansetron/dexamethasone) over a five days period. Clinical results and resource utilis...    »
 
Zeitschriftentitel:
Eur J Cancer 
Jahr:
2007 
Band / Volume:
43 
Heft / Issue:
Seitenangaben Beitrag:
299-307 
Sprache:
eng 
Print-ISSN:
0959-8049 
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik